Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | GLOTTIS Glottis Limited Pharma · Small | QUESTLAB Quest Laboratories Ltd. Pharma · SME | INFINIUM Infinium Pharmachem Ltd. Pharma · SME | NEOCHEM Neochem Bio Solutions Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 25 | 69 | 49 | 61 |
| Verdict | OVERVALUED | UNDERVALUED | FAIR VALUE | UNDERVALUED |
| Style | OVERVALUED | Deep Value | Financial Turnaround | Growth at Value |
| Piotroski | 3/9 | 6/9 | 8/9 | 7/9 |
| Valuation | 10/30 | 26/30 | 10/30 | 21/30 |
| Growth | 1/25 | 22/25 | 16/25 | 20/25 |
| Quality | 1/20 | 8/20 | 0/20 | 19/20 |
| Balance Sheet | 12/15 | 13/15 | 12/15 | 3/15 |
| Cash Flow | 0/10 | 5/10 | 8/10 | 1/10 |
| Price | ₹66.5 | ₹99 | ₹206.75 | ₹97.35 |
| P/E | 16.40 | 11.00 | 26.20 | 20.60 |
| P/B | 2.19 | 1.71 | 2.63 | — |
| ROE | 13.40% | 16.80% | 10.50% | 48.40% |
| ROCE | — | 18.40% | 13.10% | 27.20% |
| Debt / Equity | 0.19 | 0.08 | 0.00 | 1.80 |
| FCF Yield | — | 14.46% | 8.49% | 0.57% |
| Dividend Y | — | — | — | — |
| Altman Z | 7.95 | 8.86 | 6.12 | 3.55 |
| Promoter % | 74.23% | 66.78% | 64.91% | 66.72% |
| Mkt Cap (₹Cr) | 617.00 | 166.00 | 318.00 | 159.00 |
| Graham # | ₹52.83 | ₹110.43 | ₹116.77 | — |
| Fair PE | 7.9 | 42.0 | 42.0 | 42.0 |
| MoS % | -105.3% | +74.3% | +36.9% | +80.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startGLOTTIS82
QUESTLAB84
INFINIUM83
NEOCHEM94